MDXH vs RNLXY: stock comparison and AI forecast
Mdxhealth Sa (MDXH) and Renalytix Plc (RNLXY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MDXH Mdxhealth Sa
- Market Cap
- $18M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
RNLXY Renalytix Plc
- Market Cap
- n/a
- P/E Ratio
- –
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MDXH | RNLXY |
|---|---|---|
| Market Cap | $18M | – |
| EPS | – | $-0.12 |
Profitability & Margins
| Metric | MDXH | RNLXY |
|---|---|---|
| ROA | – | -520.3% |
| Gross Margin | – | 10.4% |
| Operating Margin | – | -1332.8% |
| Net Margin | – | -1179.8% |
| EBT Margin | – | -1471.3% |
| Tax Rate | – | -0.0% |
Financial Health
| Metric | MDXH | RNLXY |
|---|---|---|
| Interest Coverage | – | -26.3x |
Cash Flow
| Metric | MDXH | RNLXY |
|---|---|---|
| Operating Cash Flow | – | -$26M |
Income Statement
| Metric | MDXH | RNLXY |
|---|---|---|
| Operating Income | – | -$28M |
| Net Income | – | -$25M |
| R&D Expense | – | $9M |
| Cost of Goods Sold | – | $2M |
Dividend & Shareholder Information
| Metric | MDXH | RNLXY |
|---|---|---|
| Shares Outstanding | 91M | – |
MDXH vs RNLXY: stock comparison and AI forecast
Which one does Intratio's AI model rank higher, MDXH or RNLXY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.